Addex Raises $5.0 Million in Equity Financing

Addex Reports Full Year 2022 Financial Results and Provides Corporate Update

Addex Therapeutics to Release Full-Year 2022 Financial Results and Host Conference Call on March 30, 2023

Addex Announces Upcoming Conferences it will participate for H1 2023

Addex Regains Nasdaq Listing Compliance

Addex Strategic Partner Completes Enrollment in ADX71149 Epilepsy Phase 2 Study Part 1

Addex Provides Corporate Update and Financial Guidance

Addex and Indivior Extend Research Term of Substance Use Disorder GABAB Positive Allosteric Modulator Discovery Collaboration

Addex Reports Q3 2022 Financial Results and Provides Corporate Update

Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency